Effect of Hypopressive Exercise Versus General Strengthening in Postpartum Women

May 8, 2023 updated by: Mercè Balasch i Bernat, University of Valencia

The Effect of Hypopressive Abdominal Exercise Versus General Strengthening Exercise on Abdominopelvic and Lumbar Function in Postpartum Women

The aim of this study is to compare the effect of a hypopressive abdominal exercise program versus a general strengthening exercise program on inter-recti distance, abdominal and lumbar muscle thickness, lumbopelvic and abdominal pain and function, pelvic floor dysfunction, and quality of life in postpartum women. To evaluate the effects of the interventions, the subjects will be assessed at pre-intervention, immediately post-intervention and at 3-months follow-up.

Study Overview

Detailed Description

The aim of this study is to compare the effect of a hypopressive abdominal exercise program versus a general strengthening exercise program on inter-recti distance, abdominal and lumbar muscle thickness, lumbopelvic and abdominal pain and function, pelvic floor dysfunction, and quality of life in postpartum women. To evaluate the effects of the hypopressive exercise, the subjects will be assessed at pre-intervention, immediately post-intervention and at 3-months follow-up.

It will consist of a randomized controlled trial study. The sample will consist of women in the early postpartum period (6-8 weeks after delivery). Subjects will be randomly allocated to two different exercise programs: hypopressive abdominal exercise program and general strengthening exercise program. Both interventions will have a total duration of 6 weeks (18 sessions), 3 times a week, 30 minutes each session.

To evaluate the effects of the interventions, the subjects will be assessed at pre-intervention (6th-8th week postpartum), immediately post-intervention (12th-14th week postpartum) and at 3-months follow-up (24th-26th week postpartum). Inter-recti distance, abdominal and lumbar muscle thickness, lumbopelvic and abdominal pain and function, pelvic floor dysfunction, and quality of life will be measured.

Study Type

Interventional

Enrollment (Actual)

58

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Valencia, Spain, 46010
        • Mercè Balasch i Bernat

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • women aged between 18-45 years old
  • in the 6th-8th week postpartum
  • both vaginal or caesarean delivery
  • both primiparous or multiparous women

Exclusion Criteria:

  • previous abdominal or pelvic surgery
  • reasons to suspect metabolic, neurological or neuromuscular disease
  • multiple birth delivery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: hypopressive abdominal exercise
Participants will perform an hypopressive abdominal exercise program consisting of 18 sessions (6 weeks), 3 times a week, 30 minutes each session.
Participants will perform an hypopressive abdominal exercise program consisting of 18 sessions (6 weeks), 3 times a week, 30 minutes each session.
Active Comparator: general strengthening exercise
Participants will perform a general strengthening exercise program consisting of 18 sessions (6 weeks), 3 times a week, 30 minutes each session.
Participants will perform a general strengthening exercise program consisting of 18 sessions (6 weeks), 3 times a week, 30 minutes each session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inter-recti distance
Time Frame: pre-intervention
Inter-recti distance will be measured by ultrasonography at rest, during abdominal draw-in and abdominal curl-up, at 2 locations on the linea alba (2 cm above and below the umbilicus).
pre-intervention
Inter-recti distance
Time Frame: immediately post-intervention
Inter-recti distance will be measured by ultrasonography at rest, during abdominal draw-in and abdominal curl-up, at 2 locations on the linea alba (2 cm above and below the umbilicus).
immediately post-intervention
Inter-recti distance
Time Frame: 3-months follow-up
Inter-recti distance will be measured by ultrasonography at rest, during abdominal draw-in and abdominal curl-up, at 2 locations on the linea alba (2 cm above and below the umbilicus).
3-months follow-up
Abdominal and lumbar muscles thickness
Time Frame: pre-intervention
Transversus abdominis, obliquus internus, obliquus externus and multifidus thickness at rest and during draw-in will be measured by ultrasonography.
pre-intervention
Abdominal and lumbar muscles thickness
Time Frame: immediately post-intervention
Transversus abdominis, obliquus internus, obliquus externus and multifidus thickness at rest and during draw-in will be measured by ultrasonography.
immediately post-intervention
Abdominal and lumbar muscles thickness
Time Frame: 3-months follow-up
Transversus abdominis, obliquus internus, obliquus externus and multifidus thickness at rest and during draw-in will be measured by ultrasonography.
3-months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lumbopelvic and abdominal pain
Time Frame: pre-intervention
Lumbopelvic and abdominal pain reported by the patient will be measured using a 100-mm visual analogue scale (VAS, 0-100, 0=minimum score, 100=maximum score). Lower values represent a better outcome (less pain).
pre-intervention
Lumbopelvic and abdominal pain
Time Frame: immediately post-intervention
Lumbopelvic and abdominal pain reported by the patient will be measured using a 100-mm visual analogue scale (VAS, 0-100, 0=minimum score, 100=maximum score). Lower values represent a better outcome (less pain).
immediately post-intervention
Lumbopelvic and abdominal pain
Time Frame: 3-months follow-up
Lumbopelvic and abdominal pain reported by the patient will be measured using a 100-mm visual analogue scale (VAS, 0-100, 0=minimum score, 100=maximum score). Lower values represent a better outcome (less pain).
3-months follow-up
Lumbopelvic and abdominal muscles function
Time Frame: pre-intervention
Lumbopelvic and abdominal muscles function will be tested with the supine bridge test, the prone bridge test and the lateral bridge test.
pre-intervention
Lumbopelvic and abdominal muscles function
Time Frame: immediately post-intervention
Lumbopelvic and abdominal muscles function will be tested with the supine bridge test, the prone bridge test and the lateral bridge test.
immediately post-intervention
Lumbopelvic and abdominal muscles function
Time Frame: 3-months follow-up
Lumbopelvic and abdominal muscles function will be tested with the supine bridge test, the prone bridge test and the lateral bridge test.
3-months follow-up
Lumbar disability
Time Frame: pre-intervention
Lumbar disability will be evaluated by the Oswestry Disability Index (ODI)
pre-intervention
Lumbar disability
Time Frame: immediately post-intervention
Lumbar disability will be evaluated by the Oswestry Disability Index (ODI)
immediately post-intervention
Lumbar disability
Time Frame: 3-months follow-up
Lumbar disability will be evaluated by the Oswestry Disability Index (ODI)
3-months follow-up
Severity of the urinary incontinence
Time Frame: pre-intervention
The severity of the urinary incontinence will be assessed using the Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-IU-SF) (0-21).
pre-intervention
Severity of the urinary incontinence
Time Frame: immediately post-intervention
The severity of the urinary incontinence will be assessed using the Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-IU-SF) (0-21).
immediately post-intervention
Severity of the urinary incontinence
Time Frame: 3-months follow-up
The severity of the urinary incontinence will be assessed using the Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-IU-SF) (0-21).
3-months follow-up
Sexual dysfunction
Time Frame: pre-intervention
Sexual dysfunction will be assessed using the 6-item Female Sexual Function Index (FSFI-6) (5-30).
pre-intervention
Sexual dysfunction
Time Frame: immediately post-intervention
Sexual dysfunction will be assessed using the 6-item Female Sexual Function Index (FSFI-6) (5-30).
immediately post-intervention
Sexual dysfunction
Time Frame: 3-months follow-up
Sexual dysfunction will be assessed using the 6-item Female Sexual Function Index (FSFI-6) (5-30).
3-months follow-up
Self-reported quality of life
Time Frame: pre-intervention
Self-reported quality of life will be evaluated with the Short Form-36 Health Survey (SF-36). In this scale, higher scores indicate higher quality of life.
pre-intervention
Self-reported quality of life
Time Frame: immediately post-intervention
Self-reported quality of life will be evaluated with the Short Form-36 Health Survey (SF-36). In this scale, higher scores indicate higher quality of life.
immediately post-intervention
Self-reported quality of life
Time Frame: 3-months follow-up
Self-reported quality of life will be evaluated with the Short Form-36 Health Survey (SF-36). In this scale, higher scores indicate higher quality of life.
3-months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mercè B Balasch i Bernat, PhD, PT, Department of Physiotherapy. Faculty of Physioltherapy. Universitat de València

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2018

Primary Completion (Actual)

December 30, 2022

Study Completion (Actual)

February 15, 2023

Study Registration Dates

First Submitted

May 25, 2019

First Submitted That Met QC Criteria

September 9, 2019

First Posted (Actual)

September 10, 2019

Study Record Updates

Last Update Posted (Actual)

May 9, 2023

Last Update Submitted That Met QC Criteria

May 8, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postpartum Women

Clinical Trials on hypopressive abdominal exercise

Subscribe